{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T08:27:51Z","timestamp":1775982471114,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"High Q Foundation","award":["NS048181"],"award-info":[{"award-number":["NS048181"]}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001671","name":"the Hereditary Disease Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.nbd.2011.03.017","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T17:47:00Z","timestamp":1302198420000},"page":"248-256","source":"Crossref","is-referenced-by-count":35,"title":["Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay"],"prefix":"10.1016","volume":"43","author":[{"given":"Peter H.","family":"Reinhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Essrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Eudailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Todd","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Turmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.03.017_bb0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.03.017_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","article-title":"Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity","volume":"15","author":"Apostol","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.03.017_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","article-title":"CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice","volume":"39","author":"Apostol","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2011.03.017_bb0030","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pages","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2010.04.015","article-title":"Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease","volume":"39","author":"Braithwaite","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.03.017_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/15406580360545053","article-title":"Identification of signal transduction pathways used by orphan g protein-coupled receptors","volume":"1","author":"Bresnick","year":"2003","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0045","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders","volume":"7","author":"Butler","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.03.017_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bmcl.2005.09.020","article-title":"Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists","volume":"16","author":"Cole","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2011.03.017_bb0070","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/hmg\/ddq055","article-title":"CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease","volume":"19","author":"Crittenden","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.03.017_bb0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0080","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/onc.2008.301","article-title":"JNK signaling in apoptosis","volume":"27","author":"Dhanasekaran","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2011.03.017_bb0085","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.03.017_bb0090","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1523\/JNEUROSCI.4454-03.2004","article-title":"Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices","volume":"24","author":"Diogenes","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.drudis.2009.02.006","article-title":"Small molecule drug discovery for Huntington's disease","volume":"14","author":"Fecke","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.nbd.2011.03.017_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2009.06.008","article-title":"Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial","volume":"16","author":"Fernandez","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.03.017_bb0105","doi-asserted-by":"crossref","unstructured":"Ferre, S., et al., 2007. Adenosine Receptor Heteromers and Their Integrative Role in Striatal Function. TheScientificWorldJOURNAL. In press.","DOI":"10.1100\/tsw.2007.211"},{"key":"10.1016\/j.nbd.2011.03.017_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nbt0107-17","article-title":"HDAC inhibitors overcome first hurdle","volume":"25","author":"Garber","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.03.017_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","article-title":"Pathological cell\u2013cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease","volume":"2","author":"Gu","year":"2007","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.nbd.2011.03.017_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell\u2013cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.03.017_bb0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tibs.2006.06.009","article-title":"Huntington's disease: seeing the pathogenic process through a genetic lens","volume":"31","author":"Gusella","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0140","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2011.03.017_bb0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nchembio.467","article-title":"Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins","volume":"6","author":"Hoffstrom","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0155","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: from pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2011.03.017_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0896-6273(93)90306-C","article-title":"Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells","volume":"10","author":"Ip","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.03.017_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2011.03.017_bb0175","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0180","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001271_erratum","article-title":"NF-kappaB in the nervous system","volume":"2","author":"Kaltschmidt","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0185","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2011.03.017_bb0190","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0195","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease","volume":"285","author":"Landles","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.03.017_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568008053174723","article-title":"CXCR3-binding chemokines: novel multifunctional therapeutic targets","volume":"5","author":"Lazzeri","year":"2005","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"10.1016\/j.nbd.2011.03.017_bb0205","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1073\/pnas.061020198","article-title":"Activation of Trk neurotrophin receptors in the absence of neurotrophins","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2011.03.017_bb0210","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0896-6273(94)90412-X","article-title":"Neuronal transfection in brain slices using particle-mediated gene transfer","volume":"13","author":"Lo","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.03.017_bb0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0225","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-kappaB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2011.03.017_bb0230","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0896-6273(00)80316-5","article-title":"Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth","volume":"18","author":"McAllister","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.03.017_bb0235","series-title":"29th National Medicinal Chemistry Symposium","article-title":"Discovery and development of a CXCR3 antagonist T487 as therapy for Th1-mediated immune disorders","author":"Medina","year":"2004"},{"key":"10.1016\/j.nbd.2011.03.017_bb0240","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.03.017_bb0245","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1074\/jbc.M212049200","article-title":"Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway","volume":"278","author":"Merienne","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.03.017_bb0250","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1523\/JNEUROSCI.1856-06.2006","article-title":"Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors","volume":"26","author":"Mojsilovic-Petrovic","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0255","doi-asserted-by":"crossref","unstructured":"M\u00f6ller, T., Neuroinflammation in Huntington's disease. Journal of Neural Transmission. 117, 1001\u20131008.","DOI":"10.1007\/s00702-010-0430-7"},{"key":"10.1016\/j.nbd.2011.03.017_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","article-title":"Implication of the JNK pathway in a rat model of Huntington's disease","volume":"215","author":"Perrin","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0275","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","article-title":"A critical evaluation of adenosine A2a receptors as potentially \u201cDruggable\u201d targets in Huntington's disease","volume":"14","author":"Popoli","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2011.03.017_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2006.05.036","article-title":"Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors","volume":"404","author":"Pousinha","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.03.017_bb0290","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1523\/JNEUROSCI.0010-04.2004","article-title":"Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes","volume":"24","author":"Rajagopal","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0295","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1523\/JNEUROSCI.2451-04.2004","article-title":"CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion","volume":"24","author":"Rappert","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0300","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/hmg\/ddm134","article-title":"Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase","volume":"16","author":"Scappini","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.03.017_bb0305","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0310","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0315","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1523\/JNEUROSCI.5255-07.2008","article-title":"A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs","volume":"28","author":"Shen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0320","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-0270(91)90128-M","article-title":"A simple method for organotypic cultures of nervous tissue","volume":"37","author":"Stoppini","year":"1991","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2011.03.017_bb0325","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.03.017_bb0330","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/hmg\/ddg074","article-title":"Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein","volume":"12","author":"Taylor","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.03.017_bb0335","doi-asserted-by":"crossref","unstructured":"Tebano, M. T., et al., Adenosine A2a receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. Vol. 104, 2008, pp. 279\u2013286.","DOI":"10.1111\/j.1471-4159.2007.05046.x"},{"key":"10.1016\/j.nbd.2011.03.017_bb0340","doi-asserted-by":"crossref","unstructured":"Thomas, E. A., et al., The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Vol. 105, 2008, pp. 15564\u201315569.","DOI":"10.1073\/pnas.0804249105"},{"key":"10.1016\/j.nbd.2011.03.017_bb0345","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"Thompson","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0350","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/138620708783877753","article-title":"High throughput screening for neurodegeneration and complex disease phenotypes","volume":"11","author":"Varma","year":"2008","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.nbd.2011.03.017_bb0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nchembio852","article-title":"Selective inhibitors of death in mutant huntingtin cells","volume":"3","author":"Varma","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0360","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","article-title":"Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation","volume":"12","author":"Waelter","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2011.03.017_bb0365","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.03.017_bb0370","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.1073\/pnas.0600930103","article-title":"Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2011.03.017_bb0375","doi-asserted-by":"crossref","first-page":"17210","DOI":"10.1073\/pnas.0705267104","article-title":"Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB","volume":"104","author":"Wiese","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0380","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","article-title":"Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer's disease","volume":"108","author":"Xia","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2011.03.017_bb0385","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/73911","article-title":"Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth","volume":"3","author":"Yacoubian","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2011.03.017_bb0390","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.03.017_bb0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.nbd.2011.03.017_bb0400","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T08:20:12Z","timestamp":1637482812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0969996111000994"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.03.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}